Skip to main content

Share story

Infrastructure

Palantir Partners with Ondas and World View to Advance Next Generation Multi-Domain Intelligence Platform

Palantir Technologies Inc. announced a strategic partnership with Ondas Inc. and World View Enterprises Inc. to develop and deploy AI enabled operational capabilities for persistent stratospheric aerial and land based ISR missions. The collaboration integrates World View stratospheric sensing with Ondas autonomous systems and applies Palantir Artificial Intelligence Platform to mission planning and operations. World View Stratollite platform provides persistent long dwell ISR from the stratosphere at lower cost than traditional assets. Combined with Ondas unmanned aerial ground and counter drone systems the partnership aims to create a multi domain intelligence architecture for defense and security customers. The companies are developing three programs to transform ISR mission production execution and management. Palantir Warp Speed will create a unified data foundation for supply chain and manufacturing. AI Flight Director will integrate data for mission operations while SkyWeaver will enable edge computing on the Stratollite. Work on the stratospheric systems has begun. Full integration across the portfolio is planned to start in the fourth quarter of 2026.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from World View and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.